Medicare Part Just Crossed: What Retirees Need to Know
Medicare Part B premiums rose to $202.90 per month in 2026, a 9.7% jump that tightens budgets for retirees. Here’s wh...
Daily volatility influences return paths and allocation choices. This primer covers interpretation and practical tweaks to targets and expectations.
25,212 articlesMedicare Part B premiums rose to $202.90 per month in 2026, a 9.7% jump that tightens budgets for retirees. Here’s wh...
A focused infrastructure fund rode the AI build-out to roughly 28% gains through mid-2026, underscoring how concentra...
A long-standing tax rule on Social Security benefits that was never inflation-indexed is now catching more middle-cla...
SpaceX's debut sparked a major rise in the Saudi investor's wealth as Kingdom Holding's SpaceX stake climbed, signali...
XLY relies heavily on two megacaps, exposing the fund to outsized moves from Amazon and Tesla and prompting renewed q...
A sudden burst in DRAM-focused ETFs outpaced the broader semiconductor market this month, but market watchers warn a ...
Crypto markets surged as talk of a potential Iran truce revived risk appetite. Ripple and Ethereum led gains, with Bi...
As Vanguard S&P 500 ETF continues to grow wealth for long-term investors, retirees weigh its 1.1% yield against highe...
A regulatory push to index cost basis to inflation could reshape retiree taxes on big taxable sales, with Kiplinger c...
DGRO targets companies with five straight years of dividend growth and a cap on payout ratios, aiming for a rising in...
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
April data show 4.4 months of housing supply, up from March as inventory grows. Buyers face higher rates and remote m...